Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2019-04, Vol.185 (2), p.374-377
Hauptverfasser:	Frazer, J. Kimble, Li, Kevin J., Galardy, Paul J., Perkins, Sherrie L., Auperin, Anne, Anderson, James R., Pinkerton, Ross, Buxton, Allen, Gross, Thomas G., Michon, Jean, Leverger, Guy, Weinstein, Howard J., Harrison, Lauren, Shiramizu, Bruce, Barth, Mathew J., Goldman, Stanton C., Patte, Catherine, Cairo, Mitchell S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use B cell non‐Hodgkin lymphoma Burkitt lymphoma Burkitt Lymphoma - drug therapy Burkitt's lymphoma central nervous system Central Nervous System Neoplasms - drug therapy Child Children Female Hematology Humans Immunotherapy Immunotherapy - methods Injections, Spinal Kaplan-Meier Estimate Lymphoma Lymphoma, B-Cell - drug therapy Male Monoclonal antibodies paediatric rituximab Rituximab - administration & dosage Targeted cancer therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!